• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • DMF (Drug Master Filing) – Pharmaceutical Products
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • CML (China Manufacture Licence) – Pressure vessels
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Company Profile
    • Partners
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Information
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • DMF
      • CCC
      • Pressure Vessels
    • Publications
    • Brochure
    • Online Shop
Contact
  • Home
  • News
  • Webinars
  • Cisema Webinar: Greater Bay Area Initiative and China NMPA Registration for Medtech

Cisema Webinar: Greater Bay Area Initiative and China NMPA Registration for Medtech

Wednesday, 24 March 2021 / Published in Webinars

Cisema Webinar: Greater Bay Area Initiative and China NMPA Registration for Medtech

On April 15, 2021, Cisema will cohost a webinar with the Hong Kong Medical and Health Device Industries Association (HKMHDIA).

For many years, the China and Hong Kong government have been in talks to permit sales in the Greater Bay Area of medical devices listed in Hong Kong. In the last year, the policy proposal has continued to evolve. This webinar will share an overview of the recent regulatory updates and insights about the Greater Bay Area initiative as it relates to medical devices and IVDs, with a particular focus on how manufacturers might accelerate their time into the Mainland Chinese market and eventual China NMPA registration.

Details of the webinar:

Date: 15 April 2021 (Thu)

Time: 11:00AM – 12:00PM

Format: Online

Language: English

Register here

Our speakers:

Mr. Hamish King, Chief Operating Officer, Cisema (Hong Kong) Limited

Hamish King is a lawyer by training – admitted in Hong Kong and NSW, Australia – supporting companies with difficult regulatory affairs queries for China. Formerly with UK Magic Circle Firm Linklaters in Hong Kong, he has nearly 10 years’ experience in the legal and regulatory fields and has obtained the RAC and CFA qualifications. Regularly writing articles and speaking on China market access and regulatory pathways, he currently lives in Hong Kong and specializes in NMPA registration of medical devices. Hamish has a close interest in the regulatory implications of digital healthcare and AI applications.

Mr. Jacky Li, Sales and Marketing Manager, Cisema (Hong Kong) Limited  

Jacky Li focuses on market updates of medical devices in China (including Hong Kong and the Greater Bay Area), presents market research insights in articles on Cisema’s website, and provides customized consulting services for clients.

What you can read next

Cisema Webinar on the Market Access of Cosmetic Products to China
Attend three webcasts with Cisema on February 23 – 25, 2021
Cisema Webinar with CBBC: Opportunities and Regulatory Implications Associated with the Rise of China’s Digital Economy in Healthcare

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Drug Master Filing
      • Health Food
      • Medical Device
    • RoHS
  • Publications
  • Seminars
  • Webinars

Recent Posts

  • Cisema to attend CMEF 2021

    Once again, Cisema will be participating in the...
  • Cisema Webinar Series: NMPA Registration of Medical Devices in China

    In the first webinar of the series, we were del...
  • New Regulatory Updates Concerning Health Food Filing

    On February 20, 2021, the SAMR (State Administr...
  • New Regulatory Controls to Support the CSAR Including Animal Testing Exemptions

    On March 4, 2021, the NMPA announced the Provis...
  • NMPA Amends Safety and Technical Standards for Cosmetics

    On March 2, 2021, the NMPA announced (No.17-202...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Events
  • News & Information
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP